nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Azathioprine—systemic lupus erythematosus	0.276	0.541	CbGbCtD
Trifluoperazine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0475	0.093	CbGbCtD
Trifluoperazine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0338	0.0663	CbGbCtD
Trifluoperazine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0256	0.0502	CbGbCtD
Trifluoperazine—ABCB1—Betamethasone—systemic lupus erythematosus	0.022	0.0431	CbGbCtD
Trifluoperazine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0217	0.0425	CbGbCtD
Trifluoperazine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0206	0.0403	CbGbCtD
Trifluoperazine—ABCB1—Prednisone—systemic lupus erythematosus	0.0205	0.0402	CbGbCtD
Trifluoperazine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0194	0.0381	CbGbCtD
Trifluoperazine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0169	0.11	CbGeAlD
Trifluoperazine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0128	0.0251	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—systemic lupus erythematosus	0.0103	0.0201	CbGbCtD
Trifluoperazine—HTR2A—choroid plexus—systemic lupus erythematosus	0.00846	0.0554	CbGeAlD
Trifluoperazine—S100A4—blood plasma—systemic lupus erythematosus	0.00676	0.0443	CbGeAlD
Trifluoperazine—UGT1A4—blood plasma—systemic lupus erythematosus	0.00594	0.0389	CbGeAlD
Trifluoperazine—S100A4—connective tissue—systemic lupus erythematosus	0.0036	0.0236	CbGeAlD
Trifluoperazine—S100A4—nephron tubule—systemic lupus erythematosus	0.00349	0.0229	CbGeAlD
Trifluoperazine—S100A4—skin of body—systemic lupus erythematosus	0.00325	0.0213	CbGeAlD
Trifluoperazine—S100A4—kidney—systemic lupus erythematosus	0.00307	0.0201	CbGeAlD
Trifluoperazine—TNNC1—connective tissue—systemic lupus erythematosus	0.00303	0.0199	CbGeAlD
Trifluoperazine—S100A4—cortex of kidney—systemic lupus erythematosus	0.00299	0.0196	CbGeAlD
Trifluoperazine—CYP1A2—urine—systemic lupus erythematosus	0.00289	0.019	CbGeAlD
Trifluoperazine—EBPL—lung—systemic lupus erythematosus	0.00275	0.018	CbGeAlD
Trifluoperazine—UGT1A4—kidney—systemic lupus erythematosus	0.00269	0.0176	CbGeAlD
Trifluoperazine—S100A4—lymphoid tissue—systemic lupus erythematosus	0.00263	0.0173	CbGeAlD
Trifluoperazine—EBPL—nervous system—systemic lupus erythematosus	0.00255	0.0167	CbGeAlD
Trifluoperazine—S100A4—tendon—systemic lupus erythematosus	0.00248	0.0162	CbGeAlD
Trifluoperazine—EBPL—central nervous system—systemic lupus erythematosus	0.00245	0.0161	CbGeAlD
Trifluoperazine—S100A4—bone marrow—systemic lupus erythematosus	0.0024	0.0157	CbGeAlD
Trifluoperazine—CALY—nervous system—systemic lupus erythematosus	0.00233	0.0153	CbGeAlD
Trifluoperazine—HTR2A—urine—systemic lupus erythematosus	0.00226	0.0148	CbGeAlD
Trifluoperazine—CALY—central nervous system—systemic lupus erythematosus	0.00224	0.0147	CbGeAlD
Trifluoperazine—CALM2—endothelium—systemic lupus erythematosus	0.00219	0.0144	CbGeAlD
Trifluoperazine—CALM1—endothelium—systemic lupus erythematosus	0.00218	0.0143	CbGeAlD
Trifluoperazine—S100A4—lung—systemic lupus erythematosus	0.00217	0.0142	CbGeAlD
Trifluoperazine—TNNC1—tendon—systemic lupus erythematosus	0.00208	0.0137	CbGeAlD
Trifluoperazine—HTR1A—blood plasma—systemic lupus erythematosus	0.00198	0.013	CbGeAlD
Trifluoperazine—XDH—kidney—systemic lupus erythematosus	0.00196	0.0129	CbGeAlD
Trifluoperazine—CALM2—blood plasma—systemic lupus erythematosus	0.00195	0.0128	CbGeAlD
Trifluoperazine—CALM1—blood plasma—systemic lupus erythematosus	0.00194	0.0127	CbGeAlD
Trifluoperazine—TNNC1—lung—systemic lupus erythematosus	0.00183	0.012	CbGeAlD
Trifluoperazine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00151	0.00989	CbGeAlD
Trifluoperazine—HTR2A—endothelium—systemic lupus erythematosus	0.00133	0.00871	CbGeAlD
Trifluoperazine—CALM3—nephron tubule—systemic lupus erythematosus	0.00128	0.00838	CbGeAlD
Trifluoperazine—HTR6—nervous system—systemic lupus erythematosus	0.00121	0.00794	CbGeAlD
Trifluoperazine—HTR2A—blood plasma—systemic lupus erythematosus	0.00118	0.00774	CbGeAlD
Trifluoperazine—HTR6—central nervous system—systemic lupus erythematosus	0.00117	0.00764	CbGeAlD
Trifluoperazine—SIGMAR1—nephron tubule—systemic lupus erythematosus	0.00114	0.00749	CbGeAlD
Trifluoperazine—CALM3—cortex of kidney—systemic lupus erythematosus	0.00109	0.00717	CbGeAlD
Trifluoperazine—CALM2—connective tissue—systemic lupus erythematosus	0.00104	0.00679	CbGeAlD
Trifluoperazine—CALM1—connective tissue—systemic lupus erythematosus	0.00103	0.00676	CbGeAlD
Trifluoperazine—CALM2—nephron tubule—systemic lupus erythematosus	0.001	0.00658	CbGeAlD
Trifluoperazine—CALM1—nephron tubule—systemic lupus erythematosus	0.001	0.00655	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	0.000985	0.147	CbGdCrCtD
Trifluoperazine—SIGMAR1—cortex of kidney—systemic lupus erythematosus	0.000978	0.00641	CbGeAlD
Trifluoperazine—CALM2—skin of body—systemic lupus erythematosus	0.000936	0.00613	CbGeAlD
Trifluoperazine—CALM1—skin of body—systemic lupus erythematosus	0.000932	0.00611	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	0.000929	0.139	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Dexamethasone—systemic lupus erythematosus	0.000915	0.136	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Betamethasone—systemic lupus erythematosus	0.000915	0.136	CbGdCrCtD
Trifluoperazine—CALM3—tendon—systemic lupus erythematosus	0.000907	0.00595	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Triamcinolone—systemic lupus erythematosus	0.000894	0.133	CbGdCrCtD
Trifluoperazine—CALM2—kidney—systemic lupus erythematosus	0.000883	0.00578	CbGeAlD
Trifluoperazine—CALM3—bone marrow—systemic lupus erythematosus	0.000879	0.00576	CbGeAlD
Trifluoperazine—CALM1—kidney—systemic lupus erythematosus	0.000879	0.00576	CbGeAlD
Trifluoperazine—CALM2—cortex of kidney—systemic lupus erythematosus	0.00086	0.00563	CbGeAlD
Trifluoperazine—CALM1—cortex of kidney—systemic lupus erythematosus	0.000856	0.00561	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Prednisone—systemic lupus erythematosus	0.000848	0.126	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisolone—systemic lupus erythematosus	0.000828	0.123	CbGdCrCtD
Trifluoperazine—SIGMAR1—tendon—systemic lupus erythematosus	0.000811	0.00531	CbGeAlD
Trifluoperazine—CALM3—lung—systemic lupus erythematosus	0.000796	0.00522	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—systemic lupus erythematosus	0.000786	0.00515	CbGeAlD
Trifluoperazine—ABCB1—blood plasma—systemic lupus erythematosus	0.000774	0.00507	CbGeAlD
Trifluoperazine—CALM2—lymphoid tissue—systemic lupus erythematosus	0.000758	0.00497	CbGeAlD
Trifluoperazine—CALM1—lymphoid tissue—systemic lupus erythematosus	0.000755	0.00494	CbGeAlD
Trifluoperazine—HRH1—connective tissue—systemic lupus erythematosus	0.000753	0.00493	CbGeAlD
Trifluoperazine—CHRM2—nervous system—systemic lupus erythematosus	0.000726	0.00476	CbGeAlD
Trifluoperazine—CALM2—tendon—systemic lupus erythematosus	0.000713	0.00467	CbGeAlD
Trifluoperazine—SIGMAR1—lung—systemic lupus erythematosus	0.000712	0.00466	CbGeAlD
Trifluoperazine—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000711	0.00466	CbGeAlD
Trifluoperazine—CALM1—tendon—systemic lupus erythematosus	0.000709	0.00465	CbGeAlD
Trifluoperazine—HTR2C—nervous system—systemic lupus erythematosus	0.0007	0.00459	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—systemic lupus erythematosus	0.000699	0.00458	CbGeAlD
Trifluoperazine—CALM2—bone marrow—systemic lupus erythematosus	0.00069	0.00452	CbGeAlD
Trifluoperazine—CALM1—bone marrow—systemic lupus erythematosus	0.000687	0.0045	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—systemic lupus erythematosus	0.000674	0.00442	CbGeAlD
Trifluoperazine—HTR2A—connective tissue—systemic lupus erythematosus	0.000629	0.00412	CbGeAlD
Trifluoperazine—CALM2—lung—systemic lupus erythematosus	0.000625	0.0041	CbGeAlD
Trifluoperazine—CALM1—lung—systemic lupus erythematosus	0.000623	0.00408	CbGeAlD
Trifluoperazine—HTR1A—nervous system—systemic lupus erythematosus	0.000589	0.00386	CbGeAlD
Trifluoperazine—CALM2—nervous system—systemic lupus erythematosus	0.000579	0.00379	CbGeAlD
Trifluoperazine—CALM1—nervous system—systemic lupus erythematosus	0.000576	0.00378	CbGeAlD
Trifluoperazine—DRD2—lung—systemic lupus erythematosus	0.000575	0.00377	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—systemic lupus erythematosus	0.000567	0.00372	CbGeAlD
Trifluoperazine—CALM2—central nervous system—systemic lupus erythematosus	0.000558	0.00365	CbGeAlD
Trifluoperazine—CALM1—central nervous system—systemic lupus erythematosus	0.000555	0.00364	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—systemic lupus erythematosus	0.000543	0.00356	CbGeAlD
Trifluoperazine—HTR2A—kidney—systemic lupus erythematosus	0.000535	0.00351	CbGeAlD
Trifluoperazine—DRD2—nervous system—systemic lupus erythematosus	0.000532	0.00349	CbGeAlD
Trifluoperazine—ADRA1A—central nervous system—systemic lupus erythematosus	0.000523	0.00343	CbGeAlD
Trifluoperazine—HRH1—tendon—systemic lupus erythematosus	0.000517	0.00339	CbGeAlD
Trifluoperazine—DRD2—central nervous system—systemic lupus erythematosus	0.000513	0.00336	CbGeAlD
Trifluoperazine—CYP1A2—lung—systemic lupus erythematosus	0.000485	0.00318	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—systemic lupus erythematosus	0.000456	0.448	CrCbGaD
Trifluoperazine—HRH1—lung—systemic lupus erythematosus	0.000454	0.00297	CbGeAlD
Trifluoperazine—HTR2A—tendon—systemic lupus erythematosus	0.000432	0.00283	CbGeAlD
Trifluoperazine—HRH1—nervous system—systemic lupus erythematosus	0.00042	0.00275	CbGeAlD
Trifluoperazine—HRH1—central nervous system—systemic lupus erythematosus	0.000405	0.00265	CbGeAlD
Trifluoperazine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000399	0.00261	CbGeAlD
Trifluoperazine—SIGMAR1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000396	0.059	CbGdCrCtD
Trifluoperazine—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000391	0.00212	CcSEcCtD
Trifluoperazine—Anorexia—Leflunomide—systemic lupus erythematosus	0.000384	0.00208	CcSEcCtD
Trifluoperazine—HTR2A—lung—systemic lupus erythematosus	0.000379	0.00248	CbGeAlD
Trifluoperazine—Weight increased—Betamethasone—systemic lupus erythematosus	0.000377	0.00205	CcSEcCtD
Trifluoperazine—Weight increased—Dexamethasone—systemic lupus erythematosus	0.000377	0.00205	CcSEcCtD
Trifluoperazine—Hypotension—Leflunomide—systemic lupus erythematosus	0.000376	0.00204	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000374	0.00203	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000374	0.00203	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—systemic lupus erythematosus	0.00037	0.00201	CcSEcCtD
Trifluoperazine—Nervousness—Cyclosporine—systemic lupus erythematosus	0.00037	0.002	CcSEcCtD
Trifluoperazine—Muscular weakness—Prednisone—systemic lupus erythematosus	0.000369	0.002	CcSEcCtD
Trifluoperazine—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000366	0.00198	CcSEcCtD
Trifluoperazine—Insomnia—Leflunomide—systemic lupus erythematosus	0.000364	0.00197	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—systemic lupus erythematosus	0.000361	0.00196	CcSEcCtD
Trifluoperazine—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000361	0.00195	CcSEcCtD
Trifluoperazine—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.000359	0.00195	CcSEcCtD
Trifluoperazine—Vision blurred—Cyclosporine—systemic lupus erythematosus	0.000359	0.00194	CcSEcCtD
Trifluoperazine—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.000357	0.00193	CcSEcCtD
Trifluoperazine—Tremor—Cyclosporine—systemic lupus erythematosus	0.000357	0.00193	CcSEcCtD
Trifluoperazine—HTR2A—nervous system—systemic lupus erythematosus	0.000351	0.0023	CbGeAlD
Trifluoperazine—ABCB1—kidney—systemic lupus erythematosus	0.000351	0.0023	CbGeAlD
Trifluoperazine—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.00035	0.0019	CcSEcCtD
Trifluoperazine—Agitation—Cyclosporine—systemic lupus erythematosus	0.00035	0.0019	CcSEcCtD
Trifluoperazine—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000348	0.00189	CcSEcCtD
Trifluoperazine—Angioedema—Cyclosporine—systemic lupus erythematosus	0.000348	0.00189	CcSEcCtD
Trifluoperazine—Fatigue—Leflunomide—systemic lupus erythematosus	0.000347	0.00188	CcSEcCtD
Trifluoperazine—Erythema—Prednisolone—systemic lupus erythematosus	0.000346	0.00188	CcSEcCtD
Trifluoperazine—Constipation—Leflunomide—systemic lupus erythematosus	0.000344	0.00187	CcSEcCtD
Trifluoperazine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000342	0.00224	CbGeAlD
Trifluoperazine—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.000341	0.00185	CcSEcCtD
Trifluoperazine—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000341	0.00185	CcSEcCtD
Trifluoperazine—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000339	0.00184	CcSEcCtD
Trifluoperazine—Erythema—Hydrocortisone—systemic lupus erythematosus	0.000338	0.00183	CcSEcCtD
Trifluoperazine—HTR2A—central nervous system—systemic lupus erythematosus	0.000338	0.00222	CbGeAlD
Trifluoperazine—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000337	0.00183	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.000333	0.0018	CcSEcCtD
Trifluoperazine—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000332	0.0018	CcSEcCtD
Trifluoperazine—Cough—Cyclosporine—systemic lupus erythematosus	0.000332	0.0018	CcSEcCtD
Trifluoperazine—Convulsion—Cyclosporine—systemic lupus erythematosus	0.00033	0.00179	CcSEcCtD
Trifluoperazine—Weight increased—Prednisone—systemic lupus erythematosus	0.000329	0.00178	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisolone—systemic lupus erythematosus	0.000326	0.00177	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000326	0.00177	CcSEcCtD
Trifluoperazine—Cough—Mycophenolate mofetil—systemic lupus erythematosus	0.000324	0.00176	CcSEcCtD
Trifluoperazine—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000322	0.00174	CcSEcCtD
Trifluoperazine—Urticaria—Leflunomide—systemic lupus erythematosus	0.00032	0.00173	CcSEcCtD
Trifluoperazine—Erythema—Triamcinolone—systemic lupus erythematosus	0.000319	0.00173	CcSEcCtD
Trifluoperazine—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000318	0.00172	CcSEcCtD
Trifluoperazine—Erythema—Methylprednisolone—systemic lupus erythematosus	0.000318	0.00172	CcSEcCtD
Trifluoperazine—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000317	0.00172	CcSEcCtD
Trifluoperazine—Angioedema—Prednisolone—systemic lupus erythematosus	0.000316	0.00172	CcSEcCtD
Trifluoperazine—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000314	0.0017	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000311	0.00168	CcSEcCtD
Trifluoperazine—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000309	0.00168	CcSEcCtD
Trifluoperazine—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000309	0.00168	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000303	0.00164	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—systemic lupus erythematosus	0.000302	0.00164	CcSEcCtD
Trifluoperazine—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000302	0.00164	CcSEcCtD
Trifluoperazine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000301	0.00197	CbGeAlD
Trifluoperazine—Convulsion—Prednisolone—systemic lupus erythematosus	0.0003	0.00163	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—systemic lupus erythematosus	0.000299	0.00162	CcSEcCtD
Trifluoperazine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000297	0.00161	CcSEcCtD
Trifluoperazine—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000296	0.00161	CcSEcCtD
Trifluoperazine—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000294	0.0016	CcSEcCtD
Trifluoperazine—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000293	0.00159	CcSEcCtD
Trifluoperazine—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000291	0.00158	CcSEcCtD
Trifluoperazine—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.00029	0.00157	CcSEcCtD
Trifluoperazine—Erythema—Dexamethasone—systemic lupus erythematosus	0.000289	0.00157	CcSEcCtD
Trifluoperazine—Erythema—Betamethasone—systemic lupus erythematosus	0.000289	0.00157	CcSEcCtD
Trifluoperazine—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000289	0.00157	CcSEcCtD
Trifluoperazine—Asthenia—Leflunomide—systemic lupus erythematosus	0.000289	0.00157	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—systemic lupus erythematosus	0.000287	0.00155	CcSEcCtD
Trifluoperazine—Pruritus—Leflunomide—systemic lupus erythematosus	0.000285	0.00154	CcSEcCtD
Trifluoperazine—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000283	0.00153	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000283	0.00153	CcSEcCtD
Trifluoperazine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000282	0.00153	CcSEcCtD
Trifluoperazine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000281	0.00152	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.000278	0.00151	CcSEcCtD
Trifluoperazine—Cough—Triamcinolone—systemic lupus erythematosus	0.000278	0.00151	CcSEcCtD
Trifluoperazine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000277	0.0015	CcSEcCtD
Trifluoperazine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000276	0.0015	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000276	0.0015	CcSEcCtD
Trifluoperazine—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000276	0.0015	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.000276	0.00149	CcSEcCtD
Trifluoperazine—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000275	0.00149	CcSEcCtD
Trifluoperazine—ABCB1—bone marrow—systemic lupus erythematosus	0.000274	0.0018	CbGeAlD
Trifluoperazine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000274	0.00149	CcSEcCtD
Trifluoperazine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00027	0.00146	CcSEcCtD
Trifluoperazine—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.00027	0.00146	CcSEcCtD
Trifluoperazine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000269	0.00146	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000269	0.00146	CcSEcCtD
Trifluoperazine—Rash—Azathioprine—systemic lupus erythematosus	0.000269	0.00146	CcSEcCtD
Trifluoperazine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000268	0.00146	CcSEcCtD
Trifluoperazine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000268	0.00145	CcSEcCtD
Trifluoperazine—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000268	0.00145	CcSEcCtD
Trifluoperazine—Headache—Azathioprine—systemic lupus erythematosus	0.000267	0.00145	CcSEcCtD
Trifluoperazine—Dizziness—Leflunomide—systemic lupus erythematosus	0.000266	0.00144	CcSEcCtD
Trifluoperazine—Constipation—Cyclosporine—systemic lupus erythematosus	0.000266	0.00144	CcSEcCtD
Trifluoperazine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000265	0.00144	CcSEcCtD
Trifluoperazine—Angioedema—Betamethasone—systemic lupus erythematosus	0.000264	0.00143	CcSEcCtD
Trifluoperazine—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000264	0.00143	CcSEcCtD
Trifluoperazine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000263	0.00143	CcSEcCtD
Trifluoperazine—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000263	0.00143	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.00026	0.00141	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000259	0.00141	CcSEcCtD
Trifluoperazine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000259	0.0014	CcSEcCtD
Trifluoperazine—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000258	0.0014	CcSEcCtD
Trifluoperazine—Insomnia—Prednisolone—systemic lupus erythematosus	0.000256	0.00139	CcSEcCtD
Trifluoperazine—Rash—Leflunomide—systemic lupus erythematosus	0.000254	0.00138	CcSEcCtD
Trifluoperazine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000254	0.00137	CcSEcCtD
Trifluoperazine—Nausea—Azathioprine—systemic lupus erythematosus	0.000253	0.00137	CcSEcCtD
Trifluoperazine—Headache—Leflunomide—systemic lupus erythematosus	0.000252	0.00137	CcSEcCtD
Trifluoperazine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000252	0.00137	CcSEcCtD
Trifluoperazine—Erythema—Prednisone—systemic lupus erythematosus	0.000252	0.00136	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000251	0.00136	CcSEcCtD
Trifluoperazine—Convulsion—Betamethasone—systemic lupus erythematosus	0.00025	0.00136	CcSEcCtD
Trifluoperazine—Convulsion—Dexamethasone—systemic lupus erythematosus	0.00025	0.00136	CcSEcCtD
Trifluoperazine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00025	0.00135	CcSEcCtD
Trifluoperazine—ABCB1—lung—systemic lupus erythematosus	0.000249	0.00163	CbGeAlD
Trifluoperazine—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000247	0.00134	CcSEcCtD
Trifluoperazine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000246	0.00133	CcSEcCtD
Trifluoperazine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00131	CcSEcCtD
Trifluoperazine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000241	0.0013	CcSEcCtD
Trifluoperazine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.00024	0.0013	CcSEcCtD
Trifluoperazine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00024	0.0013	CcSEcCtD
Trifluoperazine—Nausea—Leflunomide—systemic lupus erythematosus	0.000239	0.0013	CcSEcCtD
Trifluoperazine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000238	0.00129	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000237	0.00129	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000236	0.00128	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000236	0.00128	CcSEcCtD
Trifluoperazine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000235	0.00127	CcSEcCtD
Trifluoperazine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000235	0.00127	CcSEcCtD
Trifluoperazine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000232	0.00126	CcSEcCtD
Trifluoperazine—Agitation—Prednisone—systemic lupus erythematosus	0.000231	0.00125	CcSEcCtD
Trifluoperazine—ABCB1—nervous system—systemic lupus erythematosus	0.00023	0.00151	CbGeAlD
Trifluoperazine—Angioedema—Prednisone—systemic lupus erythematosus	0.00023	0.00125	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000229	0.00124	CcSEcCtD
Trifluoperazine—Anorexia—Betamethasone—systemic lupus erythematosus	0.000225	0.00122	CcSEcCtD
Trifluoperazine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000225	0.00122	CcSEcCtD
Trifluoperazine—Urticaria—Prednisolone—systemic lupus erythematosus	0.000225	0.00122	CcSEcCtD
Trifluoperazine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000224	0.00121	CcSEcCtD
Trifluoperazine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000224	0.00121	CcSEcCtD
Trifluoperazine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000223	0.00121	CcSEcCtD
Trifluoperazine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000223	0.00121	CcSEcCtD
Trifluoperazine—ABCB1—central nervous system—systemic lupus erythematosus	0.000222	0.00145	CbGeAlD
Trifluoperazine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.00022	0.00119	CcSEcCtD
Trifluoperazine—Hypotension—Betamethasone—systemic lupus erythematosus	0.00022	0.00119	CcSEcCtD
Trifluoperazine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00022	0.00119	CcSEcCtD
Trifluoperazine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000219	0.00119	CcSEcCtD
Trifluoperazine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000218	0.00118	CcSEcCtD
Trifluoperazine—Convulsion—Prednisone—systemic lupus erythematosus	0.000218	0.00118	CcSEcCtD
Trifluoperazine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000217	0.00118	CcSEcCtD
Trifluoperazine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00116	CcSEcCtD
Trifluoperazine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000213	0.00116	CcSEcCtD
Trifluoperazine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000213	0.00116	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—systemic lupus erythematosus	0.00021	0.00114	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000208	0.00113	CcSEcCtD
Trifluoperazine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000207	0.00112	CcSEcCtD
Trifluoperazine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000206	0.00112	CcSEcCtD
Trifluoperazine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000206	0.00111	CcSEcCtD
Trifluoperazine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000205	0.00111	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000205	0.00111	CcSEcCtD
Trifluoperazine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000205	0.00111	CcSEcCtD
Trifluoperazine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000205	0.00111	CcSEcCtD
Trifluoperazine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000203	0.0011	CcSEcCtD
Trifluoperazine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000203	0.0011	CcSEcCtD
Trifluoperazine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000203	0.0011	CcSEcCtD
Trifluoperazine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.00109	CcSEcCtD
Trifluoperazine—Skin disorder—Prednisone—systemic lupus erythematosus	0.0002	0.00108	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000198	0.00107	CcSEcCtD
Trifluoperazine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000198	0.00107	CcSEcCtD
Trifluoperazine—Rash—Cyclosporine—systemic lupus erythematosus	0.000196	0.00106	CcSEcCtD
Trifluoperazine—Anorexia—Prednisone—systemic lupus erythematosus	0.000196	0.00106	CcSEcCtD
Trifluoperazine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000196	0.00106	CcSEcCtD
Trifluoperazine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000195	0.00106	CcSEcCtD
Trifluoperazine—Headache—Cyclosporine—systemic lupus erythematosus	0.000195	0.00105	CcSEcCtD
Trifluoperazine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000192	0.00104	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000191	0.00104	CcSEcCtD
Trifluoperazine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.00104	CcSEcCtD
Trifluoperazine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.00103	CcSEcCtD
Trifluoperazine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00019	0.00103	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000188	0.00102	CcSEcCtD
Trifluoperazine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000187	0.00102	CcSEcCtD
Trifluoperazine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000187	0.00102	CcSEcCtD
Trifluoperazine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000187	0.00101	CcSEcCtD
Trifluoperazine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000187	0.00101	CcSEcCtD
Trifluoperazine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000186	0.00101	CcSEcCtD
Trifluoperazine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000186	0.00101	CcSEcCtD
Trifluoperazine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000186	0.00101	CcSEcCtD
Trifluoperazine—Insomnia—Prednisone—systemic lupus erythematosus	0.000186	0.00101	CcSEcCtD
Trifluoperazine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000185	0.001	CcSEcCtD
Trifluoperazine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000184	0.000997	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—systemic lupus erythematosus	0.000184	0.000995	CcSEcCtD
Trifluoperazine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000995	CcSEcCtD
Trifluoperazine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000183	0.00099	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000182	0.000988	CcSEcCtD
Trifluoperazine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00018	0.000976	CcSEcCtD
Trifluoperazine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000179	0.000968	CcSEcCtD
Trifluoperazine—Rash—Prednisolone—systemic lupus erythematosus	0.000178	0.000966	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000178	0.000965	CcSEcCtD
Trifluoperazine—Fatigue—Prednisone—systemic lupus erythematosus	0.000177	0.00096	CcSEcCtD
Trifluoperazine—Headache—Prednisolone—systemic lupus erythematosus	0.000177	0.00096	CcSEcCtD
Trifluoperazine—Constipation—Prednisone—systemic lupus erythematosus	0.000176	0.000952	CcSEcCtD
Trifluoperazine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000174	0.000944	CcSEcCtD
Trifluoperazine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000174	0.000943	CcSEcCtD
Trifluoperazine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000173	0.000937	CcSEcCtD
Trifluoperazine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000172	0.000932	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000172	0.000931	CcSEcCtD
Trifluoperazine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000172	0.00093	CcSEcCtD
Trifluoperazine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000169	0.000917	CcSEcCtD
Trifluoperazine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000169	0.000917	CcSEcCtD
Trifluoperazine—Nausea—Prednisolone—systemic lupus erythematosus	0.000168	0.00091	CcSEcCtD
Trifluoperazine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000167	0.000905	CcSEcCtD
Trifluoperazine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000167	0.000905	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000167	0.000904	CcSEcCtD
Trifluoperazine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000164	0.000889	CcSEcCtD
Trifluoperazine—Rash—Triamcinolone—systemic lupus erythematosus	0.000164	0.000888	CcSEcCtD
Trifluoperazine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000164	0.000888	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000164	0.000887	CcSEcCtD
Trifluoperazine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000164	0.000886	CcSEcCtD
Trifluoperazine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000163	0.000886	CcSEcCtD
Trifluoperazine—Urticaria—Prednisone—systemic lupus erythematosus	0.000163	0.000885	CcSEcCtD
Trifluoperazine—Headache—Triamcinolone—systemic lupus erythematosus	0.000163	0.000883	CcSEcCtD
Trifluoperazine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000162	0.000881	CcSEcCtD
Trifluoperazine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000162	0.00088	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—systemic lupus erythematosus	0.00016	0.000869	CcSEcCtD
Trifluoperazine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000156	0.000845	CcSEcCtD
Trifluoperazine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000156	0.000845	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000155	0.000842	CcSEcCtD
Trifluoperazine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000154	0.000837	CcSEcCtD
Trifluoperazine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000154	0.000835	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000153	0.00083	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000153	0.000827	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000151	0.00082	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000149	0.000809	CcSEcCtD
Trifluoperazine—Rash—Dexamethasone—systemic lupus erythematosus	0.000149	0.000806	CcSEcCtD
Trifluoperazine—Rash—Betamethasone—systemic lupus erythematosus	0.000149	0.000806	CcSEcCtD
Trifluoperazine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000149	0.000805	CcSEcCtD
Trifluoperazine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000149	0.000805	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000148	0.000802	CcSEcCtD
Trifluoperazine—Headache—Betamethasone—systemic lupus erythematosus	0.000148	0.000801	CcSEcCtD
Trifluoperazine—Headache—Dexamethasone—systemic lupus erythematosus	0.000148	0.000801	CcSEcCtD
Trifluoperazine—Asthenia—Prednisone—systemic lupus erythematosus	0.000147	0.000799	CcSEcCtD
Trifluoperazine—Pruritus—Prednisone—systemic lupus erythematosus	0.000145	0.000788	CcSEcCtD
Trifluoperazine—Nausea—Betamethasone—systemic lupus erythematosus	0.00014	0.000759	CcSEcCtD
Trifluoperazine—Nausea—Dexamethasone—systemic lupus erythematosus	0.00014	0.000759	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—systemic lupus erythematosus	0.000136	0.000739	CcSEcCtD
Trifluoperazine—Dizziness—Prednisone—systemic lupus erythematosus	0.000136	0.000736	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000136	0.000736	CcSEcCtD
Trifluoperazine—Rash—Prednisone—systemic lupus erythematosus	0.00013	0.000702	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000129	0.000701	CcSEcCtD
Trifluoperazine—Headache—Prednisone—systemic lupus erythematosus	0.000129	0.000698	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000126	0.000686	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000123	0.000668	CcSEcCtD
Trifluoperazine—Nausea—Prednisone—systemic lupus erythematosus	0.000122	0.000661	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000121	0.000658	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000114	0.000615	CcSEcCtD
Trifluoperazine—Acepromazine—ALB—systemic lupus erythematosus	0.000108	0.106	CrCbGaD
Trifluoperazine—Rash—Methotrexate—systemic lupus erythematosus	0.000108	0.000587	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000108	0.000586	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—systemic lupus erythematosus	0.000108	0.000583	CcSEcCtD
Trifluoperazine—Thioproperazine—ALB—systemic lupus erythematosus	0.000106	0.104	CrCbGaD
Trifluoperazine—Thiothixene—ALB—systemic lupus erythematosus	0.000104	0.102	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—systemic lupus erythematosus	0.000104	0.102	CrCbGaD
Trifluoperazine—Nausea—Methotrexate—systemic lupus erythematosus	0.000102	0.000553	CcSEcCtD
Trifluoperazine—Clomipramine—ALB—systemic lupus erythematosus	8.24e-05	0.0809	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—systemic lupus erythematosus	5.65e-05	0.0555	CrCbGaD
Trifluoperazine—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	1.06e-05	7.31e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.05e-05	7.27e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	1.05e-05	7.24e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.05e-05	7.21e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.04e-05	7.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.04e-05	7.21e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD80—systemic lupus erythematosus	1.04e-05	7.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD80—systemic lupus erythematosus	1.04e-05	7.21e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.02e-05	7.05e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL2—systemic lupus erythematosus	1e-05	6.9e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—systemic lupus erythematosus	9.95e-06	6.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—TYK2—systemic lupus erythematosus	9.87e-06	6.81e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	9.8e-06	6.76e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	9.75e-06	6.73e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JAK1—systemic lupus erythematosus	9.7e-06	6.69e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	9.65e-06	6.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—TYK2—systemic lupus erythematosus	9.54e-06	6.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—TYK2—systemic lupus erythematosus	9.54e-06	6.59e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	9.5e-06	6.55e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—F2—systemic lupus erythematosus	9.47e-06	6.54e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—systemic lupus erythematosus	9.46e-06	6.53e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.43e-06	6.51e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JAK1—systemic lupus erythematosus	9.38e-06	6.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JAK1—systemic lupus erythematosus	9.38e-06	6.47e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	9.32e-06	6.43e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.3e-06	6.42e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	9.3e-06	6.42e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	9.25e-06	6.39e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNG—systemic lupus erythematosus	9.24e-06	6.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCR5—systemic lupus erythematosus	9.19e-06	6.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TYK2—systemic lupus erythematosus	9.11e-06	6.29e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	9.1e-06	6.28e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	9.08e-06	6.27e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2RA—systemic lupus erythematosus	9.05e-06	6.25e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL2—systemic lupus erythematosus	8.99e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—C3—systemic lupus erythematosus	8.98e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	8.97e-06	6.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS3—systemic lupus erythematosus	8.94e-06	6.17e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	8.94e-06	6.17e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNG—systemic lupus erythematosus	8.94e-06	6.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNG—systemic lupus erythematosus	8.94e-06	6.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD4—systemic lupus erythematosus	8.92e-06	6.16e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	8.91e-06	6.15e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	8.9e-06	6.14e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR5—systemic lupus erythematosus	8.89e-06	6.13e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR5—systemic lupus erythematosus	8.89e-06	6.13e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	8.85e-06	6.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TYK2—systemic lupus erythematosus	8.81e-06	6.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TYK2—systemic lupus erythematosus	8.81e-06	6.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.76e-06	6.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.76e-06	6.05e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	8.73e-06	6.03e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PPARG—systemic lupus erythematosus	8.71e-06	6.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL2—systemic lupus erythematosus	8.69e-06	6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL2—systemic lupus erythematosus	8.69e-06	6e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	8.69e-06	6e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—C3—systemic lupus erythematosus	8.68e-06	5.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—C3—systemic lupus erythematosus	8.68e-06	5.99e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS3—systemic lupus erythematosus	8.65e-06	5.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS3—systemic lupus erythematosus	8.65e-06	5.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD4—systemic lupus erythematosus	8.63e-06	5.96e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD4—systemic lupus erythematosus	8.63e-06	5.96e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	8.6e-06	5.94e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.5e-06	5.87e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	8.46e-06	5.84e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	8.44e-06	5.83e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PPARG—systemic lupus erythematosus	8.42e-06	5.81e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PPARG—systemic lupus erythematosus	8.42e-06	5.81e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CDKN1B—systemic lupus erythematosus	8.39e-06	5.79e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	8.34e-06	5.76e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	8.31e-06	5.74e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	8.29e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—systemic lupus erythematosus	8.29e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD4—systemic lupus erythematosus	8.24e-06	5.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL2—systemic lupus erythematosus	8.21e-06	5.67e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—systemic lupus erythematosus	8.18e-06	5.64e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CDKN1B—systemic lupus erythematosus	8.12e-06	5.6e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CDKN1B—systemic lupus erythematosus	8.12e-06	5.6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—systemic lupus erythematosus	8.01e-06	5.53e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—systemic lupus erythematosus	8.01e-06	5.53e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD4—systemic lupus erythematosus	7.97e-06	5.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD4—systemic lupus erythematosus	7.97e-06	5.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL2—systemic lupus erythematosus	7.94e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL2—systemic lupus erythematosus	7.94e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—systemic lupus erythematosus	7.91e-06	5.46e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—systemic lupus erythematosus	7.91e-06	5.46e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—F2—systemic lupus erythematosus	7.88e-06	5.44e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—systemic lupus erythematosus	7.83e-06	5.4e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	7.81e-06	5.39e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.8e-06	5.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CDKN1B—systemic lupus erythematosus	7.75e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CDKN1A—systemic lupus erythematosus	7.74e-06	5.34e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.74e-06	5.34e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	7.68e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	7.67e-06	5.29e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	7.67e-06	5.29e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—F2—systemic lupus erythematosus	7.62e-06	5.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—F2—systemic lupus erythematosus	7.62e-06	5.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—systemic lupus erythematosus	7.57e-06	5.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—systemic lupus erythematosus	7.57e-06	5.23e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.56e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CD80—systemic lupus erythematosus	7.56e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	7.55e-06	5.21e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	7.54e-06	5.21e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	7.53e-06	5.2e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	7.52e-06	5.19e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.52e-06	5.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CDKN1B—systemic lupus erythematosus	7.49e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CDKN1B—systemic lupus erythematosus	7.49e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CDKN1A—systemic lupus erythematosus	7.49e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CDKN1A—systemic lupus erythematosus	7.49e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—systemic lupus erythematosus	7.49e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	7.41e-06	5.11e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	7.4e-06	5.11e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	7.39e-06	5.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EP300—systemic lupus erythematosus	7.37e-06	5.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	7.36e-06	5.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	7.36e-06	5.08e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	7.33e-06	5.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CD80—systemic lupus erythematosus	7.31e-06	5.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CD80—systemic lupus erythematosus	7.31e-06	5.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—systemic lupus erythematosus	7.24e-06	5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—systemic lupus erythematosus	7.24e-06	5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CDKN1A—systemic lupus erythematosus	7.15e-06	4.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EP300—systemic lupus erythematosus	7.13e-06	4.92e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EP300—systemic lupus erythematosus	7.13e-06	4.92e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—systemic lupus erythematosus	7.03e-06	4.85e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	7.01e-06	4.84e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.98e-06	4.82e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	6.97e-06	4.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.94e-06	4.79e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CDKN1A—systemic lupus erythematosus	6.92e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CDKN1A—systemic lupus erythematosus	6.92e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—systemic lupus erythematosus	6.85e-06	4.73e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EP300—systemic lupus erythematosus	6.8e-06	4.69e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—systemic lupus erythematosus	6.8e-06	4.69e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—systemic lupus erythematosus	6.8e-06	4.69e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	6.64e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.64e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—systemic lupus erythematosus	6.63e-06	4.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—systemic lupus erythematosus	6.63e-06	4.57e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	6.61e-06	4.56e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	6.6e-06	4.55e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EP300—systemic lupus erythematosus	6.58e-06	4.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EP300—systemic lupus erythematosus	6.58e-06	4.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.53e-06	4.51e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.52e-06	4.5e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	6.5e-06	4.49e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	6.47e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.42e-06	4.43e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.4e-06	4.42e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	6.39e-06	4.41e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	6.38e-06	4.4e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TYK2—systemic lupus erythematosus	6.38e-06	4.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	6.36e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	6.35e-06	4.38e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.29e-06	4.34e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	6.28e-06	4.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—systemic lupus erythematosus	6.26e-06	4.32e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	6.26e-06	4.32e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.26e-06	4.32e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	6.25e-06	4.31e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	6.23e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TYK2—systemic lupus erythematosus	6.17e-06	4.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TYK2—systemic lupus erythematosus	6.17e-06	4.26e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	6.15e-06	4.25e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.13e-06	4.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—systemic lupus erythematosus	6.06e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—systemic lupus erythematosus	6.06e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	6.05e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	6.04e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.03e-06	4.16e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.02e-06	4.15e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	5.94e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.93e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	5.93e-06	4.09e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.92e-06	4.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—systemic lupus erythematosus	5.91e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.9e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	5.88e-06	4.06e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	5.83e-06	4.03e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.77e-06	3.99e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.74e-06	3.96e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	5.74e-06	3.96e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	5.73e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—systemic lupus erythematosus	5.72e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—systemic lupus erythematosus	5.72e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—systemic lupus erythematosus	5.7e-06	3.93e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	5.68e-06	3.92e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	5.63e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	5.62e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.52e-06	3.81e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—systemic lupus erythematosus	5.51e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—systemic lupus erythematosus	5.51e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.43e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.42e-06	3.74e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.42e-06	3.74e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.34e-06	3.68e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.32e-06	3.67e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—systemic lupus erythematosus	5.31e-06	3.66e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—systemic lupus erythematosus	5.28e-06	3.65e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	5.27e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.25e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.25e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	5.19e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—systemic lupus erythematosus	5.13e-06	3.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—systemic lupus erythematosus	5.13e-06	3.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—systemic lupus erythematosus	5.11e-06	3.53e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—systemic lupus erythematosus	5.11e-06	3.53e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.07e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—systemic lupus erythematosus	5.02e-06	3.47e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.01e-06	3.46e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.99e-06	3.44e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.98e-06	3.44e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.9e-06	3.38e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.88e-06	3.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.86e-06	3.35e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—systemic lupus erythematosus	4.86e-06	3.35e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.84e-06	3.34e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.84e-06	3.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—systemic lupus erythematosus	4.83e-06	3.33e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—systemic lupus erythematosus	4.76e-06	3.29e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.74e-06	3.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—systemic lupus erythematosus	4.67e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—systemic lupus erythematosus	4.67e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—systemic lupus erythematosus	4.61e-06	3.18e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—systemic lupus erythematosus	4.61e-06	3.18e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	4.53e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.51e-06	3.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—systemic lupus erythematosus	4.46e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.36e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.36e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	4.35e-06	3e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	4.33e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	4.32e-06	2.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—systemic lupus erythematosus	4.31e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—systemic lupus erythematosus	4.31e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	4.14e-06	2.86e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.14e-06	2.86e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.01e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.01e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	3.82e-06	2.64e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	3.76e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	3.75e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	3.69e-06	2.55e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	3.68e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	3.45e-06	2.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—systemic lupus erythematosus	3.12e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—systemic lupus erythematosus	3.02e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—systemic lupus erythematosus	3.02e-06	2.08e-05	CbGpPWpGaD
